TERESA PERRAULT: Open Payments
NPI 1508181686 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,039 in 122 payments from 19 companies in 2025. Trend: 2023 $3,450 · 2024 $2,784 · 2025 $3,039
Food & beverage: $3,039
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 17 | $726 |
| Neurocrine BioSciences, Inc. | 24 | $700 |
| E.R. Squibb & Sons, L.L.C. | 11 | $242 |
| Vanda Pharmaceuticals Inc. | 11 | $232 |
| Alkermes, Inc. | 15 | $223 |
| ABBVIE INC. | 11 | $187 |
| Janssen Pharmaceuticals, Inc | 5 | $117 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $107 |
| Lilly USA, LLC | 3 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $63 |
Products named: Auvelity, INGREZZA, COBENFY, FANAPT, VRAYLAR, ARISTADA, SPRAVATO, CAPLYTA.
Industry payments across FL — which companies pay providers there.
